Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus

Circulation

Volumn 124, Issue 18, 2011, Pages 1927-1935

  Izmirly, Peter M ^a   Saxena, Amit ^a   Kim, Mimi Y ^b   Wang, Dan ^b   Sahl, Sara K ^a   Llanos, Carolina ^c   Friedman, Deborah ^d   Buyon, Jill P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

antibodies; cardiomyopathy; heart block; morbidity; mortality

Indexed keywords

MATERNAL ANTIBODY; RO ANTIBODY;

ADULT; ARTICLE; CAUCASIAN; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; FATALITY; FEMALE; FETUS DEATH; FETUS HEART; HEART BLOCK; HEART PACING; HEART TRANSPLANTATION; HUMAN; HYDROPS; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; NEWBORN; NEWBORN DISEASE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; RISK ASSESSMENT; RISK FACTOR; SJOEGREN LARSSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIBODIES, ANTINUCLEAR; ASIAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FETAL DEATH; FETAL DISEASES; HEART BLOCK; HISPANIC AMERICANS; HUMANS; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MORBIDITY; PREGNANCY; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 80255138211     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.033894     Document Type: Article

References (34)

1. McCue CM, Mantakas ME, Tingelstad JB. Congenital heart block in newborns of mothers with connective tissue disease. Circulation. 1977; 56:82-90. (Pubitemid 8137684)
2. Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM Jr, Noonan JA. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med. 1977;297:1204-1207. (Pubitemid 8226681)
3. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983;309:209-212. (Pubitemid 13070239)
4. Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J, Peebles C, Weston WL. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr. 1983;103:889-891. (Pubitemid 14204179)
5. Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron JC. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol. 2005;26:16-21. (Pubitemid 41537006)
6. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, Cohen MH, Nordenberg A, Van Hare GF, Friedman RA, Perez M, Cecchin F, Schneider DS, Nehgme RA, Buyon JP. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001;37:238-242. (Pubitemid 32051745)
7. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, Hamilton RM, Hornberger LK. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation. 2002;105:843-848. (Pubitemid 34174925)
8. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, Hornberger LK. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol. 2002;40:796-802. (Pubitemid 34925629)
9. Guettrot-Imbert G, Cohen L, Fermont L, Villain E, Francès C, Thiebaugeorges O, Foliguet B, Leroux G, Cacoub P, Amoura Z, Piette JC, Costedoat-Chalumeau N. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA/Ro and anti-SSB/La antibodies. J Rheumatol. 2011;38:378-386.
10. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscarà M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 2001;44: 1832-1835. (Pubitemid 32758230)
11. Cimaz R, Spence DL, Hornberger L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr. 2003;142: 678-683. (Pubitemid 36737172)
12. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum. 2004;50:3187-3194. (Pubitemid 39371995)
13. Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, Buyon JP; PRIDE Investigators. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study. Circulation. 2008;117:485-493.
14. Waltuck J, Buyon J. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med. 1994;120:544-551. (Pubitemid 24091594)
15. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, Rupel A, Saleeb S, Weston WL, Skovron ML. Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658-1666. (Pubitemid 28273312)
16. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population based study. Arthritis Rheum. 2001;44:487-488.
17. Gladman G, Silverman ED, Yuk-Law, Luy L, Boutin C, Laskin C, Smallhorn JF. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol. 2002; 19:73-80.
18. Solomon DG, Rupel A, Buyon JP. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus. 2003;12:646-647. (Pubitemid 37021804)
19. Llanos C, Izmirly PM, Katholi M, Clancy RM, Friedman DM, Kim MY, Buyon JP. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum. 2009;60: 3091-3097.
20. Izmirly PM, Llanos C, Lee LA, Askanase A, Kim MY, Buyon JP. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block. Arthritis Rheum. 2010;62:1153-1157.
21. Rivera TL, Izmirly PM, Birnbaum BK, Byrne P, Brauth JB, Katholi M, Kim MY, Fischer J, Clancy RM, Buyon JP. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis. 2009;68:828-835.
22. Villain E, Coastedoat-Chalumeau N, Marijon E, Boudjemline Y, Piette JC, Bonnet D. Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol. 2006;48:1682-1687. (Pubitemid 44528193)
23. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: a single institution's experience of 30 years. J Am Coll Cardiol. 2002;39:130-137. (Pubitemid 34059872)
24. Lopes LM, Tavares GM, Damiano AP, Lopes MA, Aiello VD, Schultz R, Zugaib M. Perinatal outcome of fetal atrioventricular block: one-hundredsixteen cases from a single institution. Circulation. 2008;118:1268-1275.
25. Eliasson H, Gardiner HM, Sharland G, Mellander M, Sonesson SE. Isolated atrioventricular block in the fetus: a retrospective multicentre study of 175 patients, Scandinavian [abstract]. J Immunol. 2010;72:263.
26. Lee LA. Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun Rev. 2005;4:207-213. (Pubitemid 40704704)
27. Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum. 2005;52:3079-3086. (Pubitemid 41447089)
28. Stagopan J, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach A. A note on competing risks in survival analysis. Br J Cancer. 2004;91: 1229-1235. (Pubitemid 39424779)
29. Lee EW, Wei LJ, Amato DA. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In Klein JP, Goel PK, eds. Survival Analysis: State of the Art. Dordrecht: Kluwer Academic Publishers 1992;237-247.
30. Trucco SM, Jaeggi E, Cuneo B, Moon-Grady AJ, Silverman E, Silverman N, Hornberger LK. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011;57:715-723.
31. Clancy RM, Marion MC, Kaufman KM, Ramos PS, Adler A; International Consortium on Systemic Lupus Erythematosus Genetics, Harley JB, Langefeld CD, Buyon JP. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum. 2010;62:3415-3424.
32. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford). 2008;47(suppl 3):iii9-iii12.
33. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002;16:847-858.
34. Lim SS, Drenkard C. Epidemiology of systemic lupus erythematosus: capturing the butterfly. Curr Rheumatol Rep. 2008;10:265-272.